Particle Sciences and HORIBA Instruments Form Strategic Relationship
February 7, 2011
BETHLEHEM, Pa. - Particle Sciences, Inc., a leading pharmaceutical CRO, is pleased to announce the establishment of a strategic alliance with HORIBA Instruments of Irvine, CA, which is the U.S. sales and marketing division of HORIBA Limited of Kyoto, Japan. This alliance assures that both client bases are provided with a total solution, combining the [...]
Carl Zeiss Receives R&D Contract for Its Gas Field Ion Source (GFIS) Technology
February 7, 2011
PEABODY/Massachusetts - Carl Zeiss today announced that it has been awarded a $22.6 million contract to develop certain nano manufacturing and imaging applications based on its revolutionary ORION™ Gas Field Ion Source (GFIS) technology. The contract was awarded to US-based Carl Zeiss NTS, LLC by the Intelligence Advanced Research Projects Activity (IARPA) under the Circuit [...]
Danaher to Acquire Beckman Coulter, Inc. for $83.50 per share or $6.8 Billion
February 7, 2011
Washington, D.C. - Danaher Corporation (NYSE:DHR) announced today that it has entered into a definitive merger agreement with Beckman Coulter, Inc. (NYSE: BEC) pursuant to which Danaher will acquire Beckman Coulter by making a cash tender offer to acquire all of the outstanding shares of common stock of Beckman Coulter at a purchase price of [...]
February 7, 2011
WASHINGTON - Bruker today announces the North American launch of its compact, fully automated and fast toxin identification system, called pTD(TM) (portable Toxin Detector), at the American Society for Microbiology (ASM) Bio-Defense and Emerging Diseases Research Meeting in Washington, DC. The novel, benchtop, push-button pTD system is intended for smaller, field and mobile laboratories for [...]
BD Announces Agreement to Acquire Accuri Cytometers, Inc.
February 7, 2011
Franklin Lakes, NJ - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it signed a definitive agreement to acquire Accuri Cytometers, Inc., an Ann Arbor, Michigan-based company that develops and manufactures personal flow cytometers for researchers. The acquisition is subject to regulatory approvals and is expected to [...]
Novasep and InstrAction Expand Alliance to Include Taxane Purification
February 7, 2011
Pompey, France and Ludwigshafen, Germany - Novasep, a leading supplier of manufacturing solutions to the life science industries, and instrAction, a manufacturer of innovative chromatographic stationary phases for API purification processes, today announce they have expanded their worldwide strategic alliance to include the purification of taxanes, a well-known class of anti-cancer compounds. This extended collaboration [...]
Thermal Gradient Announces Breakthrough in Fast PCR Device Technology
February 7, 2011
ROCHESTER, N.Y. - Thermal Gradient, a Rochester, NY biotech company, announces a breakthrough in its fast PCR technology for molecular diagnostics. PCR (polymerase chain reaction) is the preferred critical step in virtually all forms of DNA testing. The company's latest generation of amplification devices has successfully developed and demonstrated the performance of PCR at speeds [...]
AMETEK Names Mark A. Gordon Vice President and General Manager
February 7, 2011
Berwyn, PA - AMETEK, Inc. (NYSE: AME) today announced the appointment of Mark A. Gordon as Vice President and General Manager, Measurement and Power Systems, within AMETEK Aerospace & Defense. “I am very pleased that Mark has joined AMETEK Aerospace and Defense. He has extensive management experience and brings a strong marketing and operational background, [...]
New Recombinant Antibody Fragments from Randox
February 7, 2011
Crumlin, UK - Randox Life Sciences is a recognised primary manufacturer of high quality, cost-effective human recombinant proteins, recombinant antibody fragments and polyclonal and monoclonal antibodies to classic and novel targets. New Recombinant Antibody Fragments from Randox Life Sciences include: Norketamine FABP (heart sub-type) Haptoglobin Beta Chain IL18 ICAM L-Selectin Soluble VEGFR1 p53 TSH Beta [...]
Abbott Introduces Biothreat Assay for PLEX-ID™ System
February 7, 2011
Washington, D.C. - Abbott (NYSE: ABT) announced today that it has introduced the PLEX-ID™ Biothreat Assay, which is designed to detect and distinguish 17 different biothreat pathogens. This assay enables rapid and accurate detection of potentially dangerous microorganisms that could pose serious threats to human health, food, water and other resources. The PLEX-ID Biothreat Assay [...]
